Cyclo Therapeutics, Inc. (CYTH)
NASDAQ: CYTH · IEX Real-Time Price · USD
1.260
-0.070 (-5.26%)
At close: Apr 26, 2024, 4:00 PM
1.300
+0.040 (3.17%)
After-hours: Apr 26, 2024, 4:00 PM EDT
Cyclo Therapeutics Revenue
In the year 2023, Cyclo Therapeutics had annual revenue of $1.08M, a decrease of -21.76%. Revenue in the quarter ending December 31, 2023 was $311.40K with 66.70% year-over-year growth.
Revenue (ttm)
$1.08M
Revenue Growth
-21.76%
P/S Ratio
33.61
Revenue / Employee
$134,551
Employees
8
Market Cap
36.18M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.08M | -299.36K | -21.76% |
Dec 31, 2022 | 1.38M | -210.00K | -13.24% |
Dec 31, 2021 | 1.59M | 682.38K | 75.54% |
Dec 31, 2020 | 903.38K | -103.82K | -10.31% |
Dec 31, 2019 | 1.01M | -4.28K | -0.42% |
Dec 31, 2018 | 1.01M | -226.28K | -18.28% |
Dec 31, 2017 | 1.24M | -265.15K | -17.64% |
Dec 31, 2016 | 1.50M | 552.45K | 58.13% |
Dec 31, 2015 | 950.46K | -616.98K | -39.36% |
Dec 31, 2014 | 1.57M | -125.90K | -7.43% |
Dec 31, 2013 | 1.69M | 648.39K | 62.05% |
Dec 31, 2012 | 1.04M | 13.09K | 1.27% |
Dec 31, 2011 | 1.03M | 229.48K | 28.60% |
Dec 31, 2010 | 802.37K | 178.50K | 28.61% |
Dec 31, 2009 | 623.87K | 128.94K | 26.05% |
Dec 31, 2008 | 494.94K | -256.24K | -34.11% |
Dec 31, 2007 | 751.18K | 208.86K | 38.51% |
Dec 31, 2006 | 542.31K | 87.95K | 19.36% |
Dec 31, 2005 | 454.36K | -10.33K | -2.22% |
Dec 31, 2004 | 464.69K | 70.16K | 17.78% |
Dec 31, 2003 | 394.53K | -127.84K | -24.47% |
Dec 31, 2002 | 522.37K | 232.95K | 80.49% |
Dec 31, 2001 | 289.43K | 30.47K | 11.77% |
Dec 31, 2000 | 258.96K | -233.17K | -47.38% |
Dec 31, 1999 | 492.13K | 271.31K | 122.87% |
Dec 31, 1998 | 220.82K | -78.30K | -26.18% |
Dec 31, 1997 | 299.12K | -44.95K | -13.06% |
Dec 31, 1996 | 344.07K | - | - |
Dec 31, 1995 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Owlet | 54.01M |
LENSAR | 42.16M |
ImmunoPrecise Antibodies | 17.67M |
Co-Diagnostics | 6.81M |
VYNE Therapeutics | 424.00K |
CYTH News
- 5 weeks ago - Cyclo Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update - Business Wire
- 6 weeks ago - Cyclo Therapeutics Announces Issuance of U.S. Patent Covering the Use of Trappsol® Cyclo™ for the Treatment of Alzheimer's Disease - Business Wire
- 3 months ago - Cyclo Therapeutics Announces Allowance of Patent Application for Treatment of Alzheimer's Disease from the U.S. Patent and Trademark Office - Business Wire
- 4 months ago - Cyclo Therapeutics, Inc. Completes Merger with Applied Molecular Transport Inc. - Business Wire
- 4 months ago - Cyclo Therapeutics Announces Positive Outcome from Type C Meeting with the U.S. FDA Discussing Trappsol® Cyclo™ Clinical Program for the Treatment of Niemann-Pick Disease Type C1 - Business Wire
- 5 months ago - APPLIED MOLECULAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Applied Molecular Transport Inc. - AMTI - Business Wire
- 5 months ago - Cyclo Therapeutics to Present at the 20th Annual WORLDSymposium™ 2024 - Business Wire
- 5 months ago - Cyclo Therapeutics Reports Third Quarter 2023 Financial Results - Business Wire